FDA Inspection
ATSF NW OfficeATSF NW Office – FDA Inspection, Jan 11, 2023
Record Details
This FDA Inspection record concerns ATSF NW Office, with an inspection on January 11, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 865e33e0-2fe8-4193-8136-71375fdf19ac
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1195105
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of ATSF NW Office
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2026 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 9, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 16, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 12, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for ATSF NW Office
- FDA Inspection 1339400 - 2026-09-18
- FDA Inspection 1061150 - 2018-07-09
- FDA Inspection 985587 - 2016-09-16
- FDA Inspection 908774 - 2014-12-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.